We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Dr Amarnath Challapilli at Spire include:
Dr Amarnath Challapalli is a Consultant Clinical Oncologist specialising in the treatment of urological cancers with radiotherapy, brachytherapy and chemotherapy. He also specialises in the treatment of non-melanomatous skin cancer with radiotherapy. He previously worked as a Locum Consultant Clinical Oncologist at The Royal Marsden Hospital, and was appointed to a substantive post in University Hospitals Bristol NHS Foundation Trust in February 2014.
Dr Challapalli undertook his medical training at Osmania Medical College, Hyderabad, India and specialised in clinical oncology (M.D. Radiotherapy) at Postgraduate Institute of Medical Education and Research, Chandigarh, India. He worked in the UK, since 2004 as a Clinical Fellow in Bristol, Christie Hospital, Manchester and at the Hammersmith Hospital, London, during which he completed his MRCP and FRCR examinations, and obtained the Certificate of Completion of Specialist Training (CESR) in 2011.
He subsequently completed PhD at Imperial College, London in January 2014. His research focused on the translation of novel PET tracers looking at cell proliferation, apoptosis and choline metabolism into clinical studies to look at early response assessment to treatment.
Special Clinical Interests: Clinical Oncology - Radiotherapy, Chemotherapy and Radio-isotope therapy.
|Private secretary telephone||01454 456500|
22 February 2018
Nine Spire Healthcare hospitals have received a top patient safety award from health watchdogs the National Joint Regist…
08 June 2017
Spire Southampton Hospital has cemented its place as one of the top Cardiac hospitals in the country following the resul…